Skip Navigation Links
Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z




DISSS Home | Contact Us
Health and Human Services Logo


Animated FirstGov Logo - Click to enter FirstGov


References Cited in Introduction or Case Definitions on the Case Definitions Web Site

Contents
• Home - National Notifiable Diseases Surveillance System
• Overview
• Introduction
• List of Nationally Notifiable Diseases
• Alphabetical List of Case Definitions
• Definition of Terms
• Related Links
• References
  Site Search


  1. CDC. Summary of notifiable diseases, United States, 1999. MMWR 1999;48(No. 53).
  2. Koo D, Wetterhall SF. History and current status of the National Notifiable Diseases Surveillance System. Journal of Public Health Management Practice 1996;2:4-10.
  3. Sacks JJ. Utilization of case definitions and laboratory reporting in the surveillance of notifiable communicable diseases in the United States. Am J Public Health 1985;75:1420-2.
  4. CDC. Case definitions for public health surveillance, 1990. MMWR 1990;39(No. RR-13).
  5. CDC. Manual of procedures for the reporting of nationally notifiable diseases to CDC. Atlanta: US Department of Health and Human Services, Public Health Service, CDC, 1995.
  6. Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
  7. CDC. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR 1995;44:590-1.
  8. Schluter WW, Reef SE, Dykewicz DA, Jennings CE. Pseudo-outbreak of mumps--Illinois, 1995 [Abstract]. In: Program and abstracts of the 30th National Immunization Conference, Washington, DC, April 9-12, 1996.
  9. Broome CV, Fraser DW, English WJ. Pertussis--diagnostic methods and surveillance. In: Manclark CR, Hill JC, eds. International Symposium on Pertussis. Bethesda, MD: US Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1979; DHEW publication no. (NIH)79-1830:19-22.
  10. Halperin SA, Bortolussi R, Wort AJ. Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis. J Clin Microbiol 1989;27:752-7.
  11. Sutter RW, Brink EW, Cochi SL, et al. A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health 1989;79:495-8.
  12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Villanova, PA: National Committee for Clinical Laboratory Standards, 1994;14(16); NCCLS document M100-S5.
  13. CDC. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR 1996;45(No. RR-1).
  14. American Heart Association. Jones criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation 1984;69:204A-8A.

Other Useful References

  1. CDC. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR 2001;50 (No. RR-13).
  2. Chin J.  Control of communicable diseases manual. 17th ed. Washington, DC: American Public Health Association, 2000.
  3. Teutsch SM, Churchill RE. Principles and practice of public health surveillance. 2nd ed. New York, NY: Oxford University Press, 2000.
  4. Doyle, TJ. Bryan RT. Infectious disease morbidity in the US region bordering Mexico, 1990-1998. J Inf Dis 2000;182:1503-10. 
  5. Lin SS, Kelsey JL. Use of race and ethnicity in epidemiologic research: concepts, methodological issues, and suggestions for research. Epidemiol Rev 2000;22;2:187-202.
  6. Pinner RW, Koo D, Berkelman RL. Surveillance of infectious diseases. In:Lederberg J, Alexander M, Bloom RB, eds. Encyclopedia of Microbiology.  2nd ed. San Diao, CA. Academic Press. 2000;4:506-25.
  7. Effler P, Ching-Lee M, Bogard A, Ieong MC, Nekomoto T, Jernigan D.  Statewide system of electronic notifiable disease reporting from clinical laboratories: Comparing automated reporting with conventional methods. JAMA 1999;282(19):1845-50.
  8. Koo D, Caldwell B. The role of providers and health plans in infectious disease surveillance.  Effective Clinical Practice 1999;2(5):247-52. 
  9. Roush S, Birkhead G, Koo D, Cobb A, Fleming D.  Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA 1999;282(2):164-70.
  10. CDC. Framework for program evaluation in public health. MMWR 1999;48 (No. RR-11).
  11. CDC. Reporting race and ethnicity data - National Electronic Telecommunications System for Surveillance, 1994-1997. MMWR 1999;48:305-12.
  12. Niskar AS, Koo D. Differences in notifiable infectious disease morbidity among adult women - United States, 1992-1994. J Womens Health 1998;7:451-8.
  13. CDC. Demographic differences in notifiable infectious disease morbidity - United States, 1992-1994. MMWR 1997;46:637-41.
  14. CDC. Historical perspectives notifiable disease surveillance and notifiable disease statistics - United States, June 1946 and June 1996. MMWR 1996;45:530-7.
  15. Koo D, Wetterhall SF. History and current status of the National Notifiable Disease Surveillance System. J Public Health Manag Pract. 1996;2;4:4-10.
  16. CDC. Ten leading nationally notifiable infectious diseases - United States, 1995. MMWR 1996;45:883-4.
  17. Thacker SB, Stroup DF. The future of national public health surveillance in the United States. J Public health Manag Pract. 1996;2;4:1-3.
  18. Osterholm MT, Birkhead GS, Meriwether RA. Impediments to public health surveillance in the 1990s: the lack of resources and the need for priorities. J Public health Manag Pract. 1996;2;4:11-15.
  19. Meriwether RA. Blueprint for a national public health surveillance system for the 21st century. J Public health Manag Pract. 1996;2;4:16-23.
  20. Baker EL, Ross D. Information and surveillance systems and community health: building the public health information infrastructure. J Public health Manag Pract. 1996;2;4:58-60.
  21. Thacker SB, Stroup DF. Future directions for comprehensive public health surveillance and health information systems in the United States. Am J Epidemiol 1994;140:383-97.
  22. CDC. Use of race and ethnicity in public health surveillance. MMWR 1993;42(No. RR-10)
  23. CDC.  Proceedings of the 1992 International Symposium on Public Health Surveillance. MMWR 1992;41(Suppl). 
  24. Chorba TL, Berkelman RL, Safford SK, et al. Mandatory reporting of infectious diseases by clinicians. JAMA 1989;262;21:3018-26.
  25. Sacks JJ. Utilization of case definitions and laboratory reporting in the surveillance of notifiable communicable diseases in the United States. AJPH 1985;75;12:1420-2.
  26. Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA 1983;249:118-5.
  27. Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States: An analytical literature review; Am J Epidemiology 2002; 155:866-74
  
 

Privacy Policy | Accessibility

DISSS Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated January 9, 2008

United States Department of Health and Human Services
Centers for Disease Control and Prevention

"Epi Info" is a trademark of the Centers for Disease Control and Prevention (CDC).